These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 6871486

  • 1. Monoclonal antibodies against human malignant melanoma.
    Sorg C, Brüggen J, Suter L, Bröcker EB.
    Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human monoclonal antibodies.
    Kan-Mitchell J, Mitchell MS.
    Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
    [No Abstract] [Full Text] [Related]

  • 4. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L, Sarcević B, Malenica B, Novak D.
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
    Abdel-Wahab Z, Darrow T, Vervaert CE, Crowley NJ, Seigler HF.
    Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW.
    Int Adv Surg Oncol; 1984 Sep; 7():241-70. PubMed ID: 6205999
    [Abstract] [Full Text] [Related]

  • 9. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
    Fukaya T, Hashimoto K, Eto H, Mehregan A.
    Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
    Herlyn M, Clark WH, Mastrangelo MJ, Guerry DP, Elder DE, LaRossa D, Hamilton R, Bondi E, Tuthill R, Steplewski Z, Koprowski H.
    Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
    Kan-Mitchell J, White WL, Mitchell MS.
    Cancer Res; 1989 Aug 15; 49(16):4536-41. PubMed ID: 2472881
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.
    Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C.
    Cancer Immunol Immunother; 1983 Aug 15; 16(1):53-8. PubMed ID: 6556951
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against human solid tumors.
    Burtin P, Nardelli J.
    Bull Cancer; 1983 Aug 15; 70(2):108-12. PubMed ID: 6191805
    [Abstract] [Full Text] [Related]

  • 19. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
    Chee DO, Yonemoto RH, Leong SP, Richards GF, Smith VR, Klotz JL, Goto RM, Gascon RL, Drushella MM.
    Cancer Res; 1982 Aug 15; 42(8):3142-7. PubMed ID: 7046918
    [Abstract] [Full Text] [Related]

  • 20. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
    Rochaix P, Lacroix-Triki M, Lamant L, Pichereaux C, Valmary S, Puente E, Al Saati T, Monsarrat B, Susini C, Buscail L, Delsol G, Voigt JJ.
    Mod Pathol; 2003 May 15; 16(5):481-90. PubMed ID: 12748255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.